John J. Flanagan

8.3k total citations · 1 hit paper
45 papers, 4.9k citations indexed

About

John J. Flanagan is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, John J. Flanagan has authored 45 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Physiology and 10 papers in Cell Biology. Recurrent topics in John J. Flanagan's work include Lysosomal Storage Disorders Research (12 papers), Trypanosoma species research and implications (6 papers) and Cellular transport and secretion (6 papers). John J. Flanagan is often cited by papers focused on Lysosomal Storage Disorders Research (12 papers), Trypanosoma species research and implications (6 papers) and Cellular transport and secretion (6 papers). John J. Flanagan collaborates with scholars based in United States, United Kingdom and Germany. John J. Flanagan's co-authors include Yuling Luo, Nan Su, Son Bui, Xingyong Wu, Xiao-Jun Ma, S Lawrence Zipursky, James C. Clemens, Xiaojun Ma, S. Sean Millard and James S. Lewis and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

John J. Flanagan

44 papers receiving 4.8k citations

Hit Papers

RNAscope 2011 2026 2016 2021 2011 500 1000 1.5k

Peers

John J. Flanagan
Arthur R. Hand United States
Paul Denny United States
C.F. Johnston United Kingdom
Nan Su China
Gary A. Silverman United States
E. Mira Italy
Georgina Miller United States
John J. Flanagan
Citations per year, relative to John J. Flanagan John J. Flanagan (= 1×) peers Sandrine Marlin

Countries citing papers authored by John J. Flanagan

Since Specialization
Citations

This map shows the geographic impact of John J. Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Flanagan more than expected).

Fields of papers citing papers by John J. Flanagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Flanagan. The network helps show where John J. Flanagan may publish in the future.

Co-authorship network of co-authors of John J. Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Flanagan. A scholar is included among the top collaborators of John J. Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Flanagan. John J. Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flanagan, John J., et al.. (2014). Development of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA). Journal of Immunological Methods. 406. 34–42. 11 indexed citations
2.
Richter, Franziska, Sheila M. Fleming, Melanie B. Watson, et al.. (2014). A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy. Neurotherapeutics. 11(4). 840–856. 89 indexed citations
4.
Khanna, Richie, John J. Flanagan, Jessie Feng, et al.. (2012). The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease. PLoS ONE. 7(7). e40776–e40776. 66 indexed citations
5.
Benjamin, Elfrida R., Richie Khanna, Adriane Schilling, et al.. (2012). Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice. Molecular Therapy. 20(4). 717–726. 71 indexed citations
6.
Lewis, James S., Rebecca D. Chernock, Xiaojun Ma, et al.. (2012). Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status. Modern Pathology. 25(9). 1212–1220. 108 indexed citations
7.
Valenzano, Kenneth J., Richie Khanna, Allan Powe, et al.. (2011). Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders. Assay and Drug Development Technologies. 9(3). 213–235. 127 indexed citations
8.
Wu, Xiaoyang, Evan Katz, Maria Cecilia Della Valle, et al.. (2011). A pharmacogenetic approach to identify mutant forms of α‐galactosidase a that respond to a pharmacological chaperone for Fabry disease. Human Mutation. 32(8). 965–977. 65 indexed citations
9.
Masand, Ramya P., Samir K. El‐Mofty, Xiaojun Ma, et al.. (2011). Adenosquamous Carcinoma of the Head and Neck: Relationship to Human Papillomavirus and Review of the Literature. Head and Neck Pathology. 5(2). 108–116. 102 indexed citations
11.
Flanagan, John J., Barbara Rossi, Xiaoyang Wu, et al.. (2009). The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase. Human Mutation. 30(12). 1683–1692. 73 indexed citations
12.
Matthews, Benjamin J., John J. Flanagan, Daisuke Hattori, et al.. (2007). Dendrite Self-Avoidance Is Controlled by Dscam. Cell. 129(3). 593–604. 271 indexed citations
13.
Flanagan, John J. & Charles Barlowe. (2005). Cysteine-Disulfide Cross-linking to Monitor SNARE Complex Assembly during Endoplasmic Reticulum-Golgi Transport. Journal of Biological Chemistry. 281(4). 2281–2288. 16 indexed citations
14.
Flanagan, John J., Susana G. Kalko, María José Ramírez-Bajo, et al.. (2005). Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. British Journal of Haematology. 132(4). 523–529. 23 indexed citations
15.
Wojtowicz, Woj M., John J. Flanagan, S. Sean Millard, S Lawrence Zipursky, & James C. Clemens. (2004). Alternative Splicing of Drosophila Dscam Generates Axon Guidance Receptors that Exhibit Isoform-Specific Homophilic Binding. Cell. 118(5). 619–633. 245 indexed citations
16.
Clemens, James C., Guilherme Neves, Daisuke Hattori, et al.. (2004). Analysis of Dscam Diversity in Regulating Axon Guidance in Drosophila Mushroom Bodies. Neuron. 43(5). 673–686. 177 indexed citations
17.
Pera, Edgar M., et al.. (2003). Darmin is a novel secreted protein expressed during endoderm development in Xenopus. Gene Expression Patterns. 3(2). 147–152. 13 indexed citations
18.
Johnson, Arthur E., et al.. (2001). Structure, Function, and Regulation of Free and Membrane-bound Ribosomes: The View from Their Substrates and Products. Cold Spring Harbor Symposia on Quantitative Biology. 66(0). 531–542. 4 indexed citations
19.
Rush, Benjamin F., Jay Redan, John J. Flanagan, et al.. (1989). Does the Bacteremia Observed in Hemorrhagic Shock Have Clinical Significance?. Annals of Surgery. 210(3). 342–347. 52 indexed citations
20.
Spillert, Charles R., et al.. (1988). Effect of a Butter-Rich Diet on Murine Frostbite. Journal of Investigative Surgery. 1(2). 125–128. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026